• Event Type: Earnings Call for the quarter and half year ended September 30, 2026 (Q2 FY27).
  • Event Date & Time: Held on November 06, 2026 at 18:30 Hrs. (IST).
  • Purpose: Discussion of quarterly results for Q2 and half year ended September 30, 2026.
  • Regulatory Compliance: Disclosed pursuant to Regulations 30 and 46 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and in continuation to earlier disclosures dated October 21, 2026.
  • Management Participants: Not explicitly disclosed in this announcement.
  • Availability: The audio recording of the earnings call has been uploaded to the company's website at https://glandpharma.com/images/Q2_FY27.mp3.
  • UPSI Statement: The document does not contain any statement regarding unpublished price sensitive information (UPSI).

Additional Notes Section

  • Attachments: No attachments were mentioned as included with this disclosure.
  • Financial Data: No financial data, guidance references, or presentation summaries were included in this specific announcement. This is purely an intimation of the earnings call recording availability.
  • Logistical Details: Dial-in numbers and access codes were not provided as this communication refers to a completed event where the recording is already available.